News & Perspective

Oct 20, 2005

Oct 20, 2005

US funds tularemia vaccine research, secure labs

(CIDRAP News) – The US government has issued about $60 million in contracts to spur development of a vaccine against tularemia, the National Institutes of Health (NIH) announced recently.

The National Institute of Allergy and Infectious Diseases (NIAID), a division of NIH, has issued two 5-year contracts for vaccine work, the agency said earlier this month. The agency also awarded $87 million in grants to build four biosafety level 3 (BSL-3) labs.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»